Analysts' Actions: ANGI BGS ITRI REGN VRSK

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Angie's List was downgraded at Stifel Nicolaus to hold from buy. Company posted lower member and service provider metrics, Stifel Nicolaus said. Twelve-month price target is $25.

B&G Foods was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $30. Company is facing operating and integration challenges, Piper Jaffray said.

IntercontinentalExchange was downgraded to hold at TheStreet Ratings.

Itron was downgraded at Brean Capital to sell from hold. Twelve-month price target is $28. Company's 2014 guidance fell short of expectations, Brean Capital said.

Itron was downgraded at J.P. Morgan to underweight from neutral. Company slashed its guidance, J.P. Morgan said.

Itron was downgraded at Canaccord Genuity to hold. Twelve-month price target is $38. Company will likely have to overhaul the entire business, Canaccord Genuity said.

Regeneron was downgraded at Oppenheimer to perform from outperform. Valuation call, based on a 12-month price target of $325.

Concha y Toro was upgraded to buy at TheStreet Ratings.

Verisk was upgraded at Morgan Stanley to overweight. Twelve-month price target is $74. Company is near a sales inflection point and should see a higher multiple, Morgan Stanley said.

Stock Comments / EPS Changes

Alpha Natural Resources price target, EPS estimates were cut at Jefferies. Domestic inventories continue to decline, and met markets are challenging, Jefferies said. Twelve-month price target is $7.50. Buy rating.

CBS price target was lifted at UBS. Driven by strong syndication pipeline, UBS said. Twelve-month price target is $73. Buy rating.

Charles River Laboratories price target was increased at Jefferies. Preclinical improvement continues to develop and stronger orders are carrying into the first half of 2014. Twelve-month price target is $67. Buy rating.

Cisco estimates, price target were increased at MKM Partners. Estimates were raised through 2015. Product orders are not falling as much as feared and management is buying back stock, MKM Partners said. Neutral rating and new 12-month price target of $24.

Deere price target, EPS estimates were raised at UBS. Driven mostly by operating margins, UBS said. Twelve-month price target is $75. Sell rating.

Dr. Pepper Snapple numbers were boosted at Credit Suisse. Twelve-month price target is now $54. Estimates were also increased, as the company is realizing higher margins, Credit Suisse said. Neutral rating.

Energizer was added to the Focus List at Citigroup. Domestic pessimism appears overblown, as the stock is down 13% year to date, Citigroup said.

Incyte Pharmaceutical price target was increased at UBS. Driven by lower opex and timing of the PV launch, UBS said. Twelve-month price target of $90. Buy rating.

Mondelez estimates, price target were cut at Credit Suisse. Estimates were reduced through 2015. Company lowered its guidance, Credit Suisse said. Neutral rating and new 12-month price target of $35.

NVIDIA estimates, price target were increased at Jefferies. Desktop and embedded drive upside, Jefferies said. Twelve-month price target is $18. Hold rating.

Nvidia estimates, price target were increased at BMO Capital. Estimates were boosted through 2016. Company is seeing higher PC-related demand, BMO Capital said. Market Perform rating and new 12-month price target is $15.

Priceline.com numbers were raised at Credit Suisse. Twelve-month price target is now $1,450. Estimates were also increased, as the company can continue to gain market share, Credit Suisse said. Outperform rating.

Packaging Corp. numbers were raised at DA Davidson. Twelve-month price target is now $75. Estimates were also increased, as the company is seeing higher synergies, DA Davidson said. Neutral rating.

Charles Schwab numbers were cut at BMO Capital. Twelve-month price target is now $29. Estimates were also reduced, given the company's new guidance, BMO Capital said. Outperform rating.

Whole Foods Market estimates, price target were lowered at Jefferies. Comps struggled in December, weather remains disruptive, Jefferies said. Twelve-month price target is $61. Buy rating.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

View Comments (0)